Gainers
- Heart Test Laboratories HSCS stock moved upwards by 96.5% to $3.4 during Wednesday's regular session. Trading volume for Heart Test Laboratories's stock is 22.7 million as of 13:30 EST. This is 9057.6% of its average full-day volume over the last 100 days. The company's market cap stands at $28.0 million.
- Eargo EAR shares increased by 81.45% to $1.27. Trading volume for this security as of 13:30 EST is 136.4 million, which is 12586.8% of its average full-day volume over the last 100 days. The company's market cap stands at $50.0 million.
- Poseida Therapeutics PSTX stock increased by 67.81% to $4.08. The current volume of 49.9 million shares is 20987.1% of Poseida Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $255.7 million.
- Applied DNA Sciences APDN shares moved upwards by 47.14% to $4.12. Applied DNA Sciences's stock is trading at a volume of 93.0 million shares as of 13:30 EST. This is 4697.1% of its average full-day volume over the last 100 days.
- MSP Recovery MSPR stock rose 43.63% to $2.37. The current volume of 3.4 million shares is 203.0% of MSP Recovery's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $34.3 million.
- Alnylam Pharmaceuticals ALNY stock rose 41.74% to $201.24. Trading volume for Alnylam Pharmaceuticals's stock is 6.5 million as of 13:30 EST. This is 811.3% of its average full-day volume over the last 100 days. The company's, Q2 earnings came out 4 days ago.
Losers
- Meihua International MHUA stock declined by 31.3% to $4.86 during Wednesday's regular session. Trading volume for this security as of 13:30 EST is 263.1K, which is 703.1% of its average full-day volume over the last 100 days. The company's market cap stands at $116.2 million.
- Horizon Therapeutics HZNP shares declined by 20.92% to $64.95. Trading volume for Horizon Therapeutics's stock is 14.6 million as of 13:30 EST. This is 733.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.9 billion. The company's, Q2 earnings came out today.
- Merrimack Pharmaceuticals MACK shares declined by 15.27% to $4.22. The current volume of 364.4K shares is 2508.7% of Merrimack Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $56.5 million.
- BridgeBio Pharma BBIO shares fell 15.23% to $7.63. Trading volume for BridgeBio Pharma's stock is 5.2 million as of 13:30 EST. This is 240.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion.
- Altimmune ALT shares decreased by 14.31% to $10.6. Altimmune's stock is trading at a volume of 3.5 million shares as of 13:30 EST. This is 243.6% of its average full-day volume over the last 100 days.
- Geovax Labs GOVX shares fell 13.85% to $2.64. Geovax Labs's stock is trading at a volume of 21.2 million shares as of 13:30 EST. This is 87.1% of its average full-day volume over the last 100 days. The company's market cap stands at $33.0 million. The company's, Q2 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in